Osteopenia Completed Phase 1 Trials for Romosozumab (DB11866)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01101061A Single-dose Study Evaluating Romosozumab (AMG 785) in Healthy Postmenopausal Japanese and Non-Japanese WomenTreatment
NCT00950950A Study to Evaluate the Effect of Romosozumab (AMG 785) on Bone Quality of the Forearm in Postmenopausal Women With Low Bone MassTreatment
NCT01059435A First-in-human Study Evaluating Romosozumab (AMG 785) in Healthy Men and Postmenopausal WomenTreatment
NCT01825785A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785)Treatment